Abstract 399P
Background
Currently in Indonesia, colorectal cancer (CRC) is the third most commonly occurring cancer in men and the fourth in women. CRC is mostly diagnosed in the advanced stage, it’s probably caused by the difficulties in detecting colorectal cancer. Identifying risk factors of CRC is very crucial to prevent CRC. CRC risk is expected to rise continually due to dietary patterns, smoking, lack of physical activities, and other practices. This study describes the prevalence of risk factors for CRC in healthy residents of Suluhan village, Bangli District, Bali Province.
Methods
A pre-experimental cross-sectional study-based community was conduct on 18th – 19th May 2019 in Suluhan village to collect data from 77 healthy residents using validated questionnaire. We measured sociodemographic characteristics, physical activity, dietary habits, and lifestyle as risk factors of CRC. Analysis of data using chi-square with p-value ≤0.05 is categorized as significant.
Results
77 respondents were involved in this study with a mean age of 41.94 ± 9.448 years. The majority of participants were female (61 %). Mostly the residents didn’t know CRC (80.6%). The commonest risk factors for CRC among the participants were overconsumption of red meat (2 times/week and >3 times/week) (67.6 %), overweight and obesity (62.4 %), limited consumption of vegetables (62.3 %), low of physical activities (44.1%), smoking (28.6%), and limited consumption of diet fiber (10.4%). Lack of physical activity was found significantly higher in females (p = 0,000), otherwise smoking (p = 0,000) is higher in males.
Conclusions
We conclude that the highest risk factor of CRC in Suluhan village is the overconsumption of red meat, followed by overweight and obesity, limited consumption of vegetables, low physical activities, smoking, and limited consumption of diet fiber sequentially. Dietary and lifestyle risk factors for CRC are prevalent in Suluhan village and likely to increase CRC incidence if educational interventions are not implemented. Greater attention in improving residents’ knowledge of CRC risk is needed to prevent CRC in Suluhan village.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
511P - Phase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402)
Presenter: Toshio Kubo
Session: Poster display session
Resources:
Abstract
485P - A real-world experience of first-line afatinib in Korean patients with EGFR-mutant non-small cell lung cancer
Presenter: Seong Hoon Yoon
Session: Poster display session
Resources:
Abstract
522P - Weekly nab-PTX and weekly PTX for relapsed small cell lung cancer
Presenter: Hajime Oi
Session: Poster display session
Resources:
Abstract
512P - A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer
Presenter: Hisao Imai
Session: Poster display session
Resources:
Abstract
497P - Real-word efficacy of osimertinib in patients with metastatic EGFRm NSCLC: An interim analysis from a multi-center study in China
Presenter: Xiangyun Ye
Session: Poster display session
Resources:
Abstract
507P - Immune checkpoint inhibitors for patients acquired resistance to tyrosine kinase inhibitors with EGFR mutated non-small cell lung cancer: A multicenter retrospective study
Presenter: Takeshi Uenami
Session: Poster display session
Resources:
Abstract
516P - Clinical outcomes in elderly patients with advanced non-small cell lung cancer: A prospective multicenter study of the National Hospital Organization in Japan
Presenter: Masahiro Shimada
Session: Poster display session
Resources:
Abstract
486P - Phase II study of low-dose afatinib maintenance treatment for patients with EGFR-mutated non-small cell lung cancer (NJLCG1601)
Presenter: Mami Morita
Session: Poster display session
Resources:
Abstract
515P - Polypharmacy as a prognostic factor in elderly patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
Presenter: Taiki Hakozaki
Session: Poster display session
Resources:
Abstract
518P - Real world prospective clinical impact of finding actionable genomic alterations by plasma cell-free DNA next generation sequencing in advanced non-small cell lung cancer
Presenter: Beung chul Ahn
Session: Poster display session
Resources:
Abstract